Published in BMJ on July 09, 1988
Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut (2014) 2.08
Bacteria as the cause of ulcerative colitis. Gut (2001) 1.96
Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One (2010) 1.69
Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut (2003) 1.63
Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61
Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev (2005) 1.51
Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut (1992) 1.30
Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted. J Bacteriol (2005) 1.23
Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol (2009) 1.11
Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol (1997) 1.07
Measurement of motility of Helicobacter pylori, Campylobacter jejuni, and Escherichia coli by real time computer tracking using the Hobson BacTracker. J Clin Pathol (1998) 1.06
Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun (2004) 1.02
Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol (2007) 0.97
HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun (2005) 0.94
Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Gut (1993) 0.94
High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes. Dig Dis Sci (2007) 0.93
Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity. World J Gastrointest Pathophysiol (2014) 0.88
Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease. BMC Immunol (2010) 0.87
Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients. Int J Colorectal Dis (2004) 0.86
Current concept of pathophysiological understanding and natural course of ulcerative colitis. Langenbecks Arch Surg (2004) 0.83
Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease. World J Gastroenterol (2014) 0.81
Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria. World J Gastroenterol (2011) 0.80
Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease. Clin Diagn Lab Immunol (2003) 0.79
Infectious etiopathogenesis of Crohn's disease. World J Gastroenterol (2014) 0.79
Escherichia coli and ulcerative colitis. J R Soc Med (1997) 0.79
Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis. J Clin Pathol (1990) 0.78
High incidence of Crohn's disease in pre-menopausal women: Escherichia coli may be contributing. Int J Colorectal Dis (2004) 0.76
Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases. Front Immunol (2017) 0.75
Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series. BMJ Open Gastroenterol (2016) 0.75
Pathotypes and probiotics: response to a commentary on the detection of a Shiga toxin producing Escherichia coli in a Crohn's disease patient. Gut Pathog (2015) 0.75
Aetiology and pathogenesis of ulcerative colitis and Crohn's disease. Postgrad Med J (1989) 0.75
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. J Med Microbiol (1971) 11.97
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology (1982) 8.38
Pathogenesis of escherichia coli gastroenteritis in man--another mechanism. N Engl J Med (1980) 8.01
Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun (1983) 6.43
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
The fimbrial and non-fimbrial haemagglutinins of Escherichia coli. J Med Microbiol (1979) 5.46
Episome-carried surface antigen K88 of Escherichia coli. I. Transmission of the determinant of the K88 antigen and influence on the transfer of chromosomal markers. J Bacteriol (1966) 5.09
Intestinal microflora. Gastroenterology (1971) 3.86
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Mucosal adherence of human enteropathogenic Escherichia coli. Lancet (1975) 3.54
Yersinia enteritis and enterocolitis: gastroenterological aspects. Gastroenterology (1977) 2.79
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Adherence of an enteropathogenic strain of Escherichia coli to human intestinal mucosa is mediated by a colicinogenic conjugative plasmid. Infect Immun (1978) 2.14
A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons. J Pathol Bacteriol (1967) 1.84
Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology (1968) 1.80
Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75
Adhesion of enterotoxigenic Escherichia coli to human small intestinal enterocytes. Infect Immun (1985) 1.71
The faecal flora in ulcerative colitis. J Med Microbiol (1975) 1.70
Influence of inflammatory bowel disease on intestinal microflora. Gut (1978) 1.61
Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut (1980) 1.37
Analysis of antigenic determinants in cholera enterotoxin and heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli. Infect Immun (1983) 1.35
Post-dysenteric colitis. Br Med J (1950) 1.29
Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol (1987) 1.21
Models for studying the adhesion of enterobacteria to the mucosa of the human intestinal tract. Ciba Found Symp (1981) 1.18
Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut (1974) 1.15
Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation. Gastrointest Endosc (1983) 0.89
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaena. Br Med J (1973) 4.84
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Early gastric cancer in Europe. Gut (1997) 2.34
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Effect of cimetidine on the gastric bacterial flora. Lancet (1980) 2.18
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut (1986) 1.83
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
Intestinal permeability and screening tests for coeliac disease. Gut (1980) 1.81
Endoscopic mucosal resection. Endoscopy (2001) 1.76
Disinfection of gastrointestinal fibre endoscopes. Lancet (1974) 1.71
Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology (1980) 1.69
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut (1982) 1.65
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Permeability of the small intestine to substances of different molecular weight. Gut (1970) 1.61
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther (1999) 1.59
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Disinfection in upper-digestive-tract endoscopy in Britain. Lancet (1981) 1.57
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56
Cellobiose/mannitol sugar test--a sensitive tubeless test for coeliac disease: results on 1010 unselected patients. Gut (1989) 1.55
The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther (1998) 1.52
Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut (1983) 1.52
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Setting up a quality assurance program in endoscopy. Endoscopy (2003) 1.51
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50
Acute pancreatitis following endoscopic retrograde cholangiopancreatography. Clin Radiol (1983) 1.49
Abnormal intestinal permeability. An aetiological factor in chronic psychiatric disorders? Br J Psychiatry (1987) 1.45
Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate. Endoscopy (1988) 1.43
Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur J Gastroenterol Hepatol (1995) 1.42
Diagnostic yield of fibre-optic endoscopy in the operated stomach. Br J Surg (1973) 1.40
Fatal accidental ingestion of Clinitest in adult. J R Soc Med (1984) 1.39
Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology (1989) 1.38
Evaluation of four commercial automatic endoscope washing machines. Endoscopy (1992) 1.38
Patient and staff exposure to glutaraldehyde from KeyMed Auto-Disinfector endoscope washing machine. Endoscopy (1994) 1.38
Passive permeability in experimental intestinal damage in rats. Clin Sci (Lond) (1981) 1.38
Endoscopic retrograde cholangiopancreatography in the investigation and management of patients after acute pancreatitis. Br J Surg (1982) 1.38
Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut (1980) 1.37
Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut (1980) 1.37
Adhesion molecules in inflammatory bowel disease. Gut (1995) 1.36
Campylobacter pyloridis: what role in gastritis and peptic ulcer. Br Med J (Clin Res Ed) (1986) 1.36
Lundh test and ERCP in pancreatic disease. Gut (1978) 1.35
Reflux gastritis in the intact stomach. J Clin Pathol (1990) 1.35
Early gastric cancer: disease or pseudo-disease? Lancet (1998) 1.35
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut (1993) 1.32
Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut (1985) 1.28
Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol (1999) 1.28
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Intestinal permeability in rats infected by Nippostrongylus brasiliensis. Gut (1979) 1.25
Controlled trial comparing De-Nol tablets with De-Nol liquid in treatment of duodenal ulcer. Br Med J (Clin Res Ed) (1981) 1.25
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol (1995) 1.23
Diagnostic yield and effect on clinical outcomes of push enteroscopy in suspected small-bowel bleeding. Endoscopy (2000) 1.22
Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea. Br Med J (Clin Res Ed) (1984) 1.21
Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol (1987) 1.21
Clinical relevance of an unfused pancreatic duct system. Gut (1979) 1.17
Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol (1998) 1.17
Diagnosis of Helicobacter pylori infection by HpSA test. European Helicobacter pylori HpSA Study Group. Lancet (1999) 1.16
Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut (2001) 1.14
In vitro mucus glycoprotein production by colonic tissue from patients with ulcerative colitis. Gut (1988) 1.14
Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut (1990) 1.14
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter (2000) 1.12
Staphylococcal enterocolitis and inflammatory bowel disease. J Clin Pathol (1980) 1.11
The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther (1990) 1.10
Helicobacter pylori infection and dental care. Gut (1995) 1.10
Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol (1994) 1.09
Gastrointestinal endoscopy: infection and disinfection. Gut (1983) 1.09
Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists. Br Med J (Clin Res Ed) (1988) 1.07
Pseudostone at ERCP due to juxtapapillary diverticulum. Clin Radiol (1981) 1.07
Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut (1987) 1.06
Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet (1980) 1.06
Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for. Br Med Bull (1998) 1.05
Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy. Endoscopy (2001) 1.05
Pancreatogram changes in patients with calculous biliary disease. Br J Surg (1979) 1.03
Campylobacter pylori and development of duodenal ulcer. Lancet (1988) 1.03
Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut (1995) 1.03
Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth. Gut (1982) 1.03